Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01006902 · ClinicalTrials.gov registry record
Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change
A clinical trial, sponsored by University of Vermont.
- Terminated
- Registry status
- 3
- Enrollment target
NCT01006902 is a clinical trial that was terminated before completion, run by University of Vermont. The registered enrollment target is 3 participants.
The verdict
NCT01006902 was terminated before completion, sponsored by University of Vermont.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
The proposed project will document the degree of function decline, assess the relationship between function and cancer- related symptoms and evaluate relationships between function and quality of life. Participants are evaluated before therapy, after therapy and again 3 months post therapy to evaluate functional change. Knowledge gained will help us plan interventions around the time of cancer therapy to help older adults preserve or improve function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01006902
The ClinicalTrials.gov registry entry for NCT01006902 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01006902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01006902 about?
NCT01006902 is a clinical study titled "Outcomes of Oncology Therapy in the Elderly: Trajectory of Functional Decline and Correlates of Change". The proposed project will document the degree of function decline, assess the relationship between function and cancer- related symptoms and evaluate relationships between function and quality of life. Participants are evaluated before therapy, after therapy and again 3 months post therapy to evalua...
What is the current status of trial NCT01006902?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2009-11. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT01006902?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.